Oligonucleotide Therapeutics Society

Inclisiran for the treatment of heterozygous familial hyper-cholesterolemia (Raal et al., 2020)

August 18th, 2020|Categories: Late Discovery Featured Paper of the Year, Paper of the Year Award|

Raal FJ, Kallend D, Ray KK, Turner T, Koenig W, Wright RS, Wijngaard PLJ, Curcio D, Jaros MJ, Leiter LA, Kastelein JJP; ORION-9 Investigators. Lee JS, Mendell JT. Read More

Go to Top